eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | barrett esophagus |
| Comorbidity | C0017168|oesophageal reflux |
| Sentences | 13 |
| PubMedID- 26377193 | A newly identified susceptibility locus near foxp1 modifies the association of gastroesophageal reflux with barrett's esophagus. |
| PubMedID- 20086178 | Gastroesophageal reflux disease complicated by barrett's esophagus (be) is a major risk factor for esophageal adenocarcinoma (ea). |
| PubMedID- 21352563 | Treatment of gastro-oesophageal reflux in patients with barrett's oesophagus is thought to be important, as oncogenic progression may be associated with inflammation, and inflammation can be minimised by effective control of reflux [2]. |
| PubMedID- 20946664 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
| PubMedID- 23663216 | Having barrett's esophagus was associated with more severe gastroesophageal reflux symptoms, and nocturnal reflux symptoms were associated with scoring at high risk for obstructive sleep apnea. |
| PubMedID- 25804032 | [prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by barrett's esophagus]. |
| PubMedID- 21694467 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
| PubMedID- 25632808 | Adiponectin may modify the risk of barrett's esophagus in patients with gastroesophageal reflux disease. |
| PubMedID- 21636532 | Gastroesophageal reflux is associated with adenocarcinoma in barrett's esophagus, but the incidence of this tumor is rising, despite widespread use of acid-suppressing medications. |
| PubMedID- 24428806 | barrett's esophagus (be) arising from chronic gastro-oesophageal reflux (gerd) is the main pathologic precursor of esophageal adenocarcinoma (eac). |
| PubMedID- 25743462 | Both proton pump inhibitor therapy and antireflux surgery are effective at controlling endoscopic signs and symptoms of gastro-oesophageal reflux in patients with barrett's oesophagus, but often fail to eliminate pathological oesophageal acid exposure. |
| PubMedID- 23504527 | barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac). |
| PubMedID- 26032153 | Control of acid and duodenogastroesophageal reflux (dger) in patients with barrett's esophagus. |
Page: 1